Organ and kidney function preservation in renal cell carcinoma

被引:0
作者
Schenck, M. [1 ]
Eder, R. [1 ]
Ruebben, H. [1 ]
Niedworok, C. [1 ]
Tschirdewahn, S. [1 ]
机构
[1] Urol Univ Klin Essen, D-45122 Essen, Germany
来源
UROLOGE | 2014年 / 53卷 / 09期
关键词
Renal cell carcinoma; Organ-preserving renal tumour surgery; Partial nephrectomy; Survival; Therapy success; NEPHRON-SPARING SURGERY; CANCER-SPECIFIC SURVIVAL; QUALITY-OF-LIFE; RADICAL NEPHRECTOMY; RADIOFREQUENCY ABLATION; PROGNOSTIC NOMOGRAM; NATURAL-HISTORY; COMPLICATIONS; TUMORS; STRATIFICATION;
D O I
10.1007/s00120-014-3558-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The organ-preserving partial nephrectomy has increasingly established itself in small unilateral renal tumours (< 4 cm) with contralateral healthy kidney and counter gained in recent years in importance. There was found a significantly increased cardiovascular mortality rate and deteriorated quality of life, the more intact kidney tissue has been removed. In the present study, the influence of pre- and perioperative factors on direct postoperative course was examined, including 5-year survival rate and relapse behaviour after open organ-preserving partial nephrectomy in our own collective. In this retrospective study of 1657 patients were collected, who underwent surgery between 2007 and 2013 in the Department of Urology at the University Hospital Essen because of a renal tumour. 38 % of these operations (n = 636) were performed organ-preserving. In this trial there are factors identified that have an impact on need of blood transfusion and length of hospitalization in organ-preserving operation method. No independent parameter can be determined for the need of blood transfusion. Tumour size and thus time of resection procedure does not affect the need of erythrocytes administration. In addition, the tumour size influences neither the postoperative serum-haemoglobin nor serum-creatinine. Increased patient age and female gender are identified as non-modifiable factors, which cause a longer hospitalisation. Postoperative pain therapy can be considered as a variable size, which does not affect the length of hospital stay. Modifiable factors that increase the overall length of stay, however, are the type of direct postoperative monitoring (ICU vs. anaesthetic recovery room) and the administration of blood transfusions. There are constant factors, which can be associated with a longer residence time in the framework of an organ-preserving partial nephrectomy. Further there is shown evidence of the independence of the tumour size - in addition to proven good oncological results - of an extension of indication of organ-preserving nephrectomy of tumours > 4 cm.
引用
收藏
页码:1329 / 1343
页数:15
相关论文
共 50 条
  • [31] Laparoscopic ultrasonography: The wave of the future in renal cell carcinoma?
    Liu, Bitian
    Zhan, Yunhong
    Chen, Xiaonan
    Xie, Qingpeng
    Wu, Bin
    ENDOSCOPIC ULTRASOUND, 2018, 7 (03) : 161 - 167
  • [32] Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship
    Siva, Shankar
    Jackson, Price
    Kron, Tomas
    Bressel, Mathias
    Lau, Eddie
    Hofman, Michael
    Shaw, Mark
    Chander, Sarat
    Pham, Daniel
    Lawrentschuk, Nathan
    Wong, Lih-Ming
    Goad, Jeremy
    Foroudi, Farshad
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 (03) : 540 - 546
  • [33] Epidemiology, diagnosis, and surgical treatment of renal cell carcinoma
    Kurosch, M.
    Reiter, M.
    Haferkamp, A.
    ONKOLOGE, 2014, 20 (09): : 899 - 908
  • [34] The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System
    Mason, Ross
    Kapoor, Anil
    Liu, Zhihui
    Saarela, Olli
    Tanguay, Simon
    Jewett, Michael
    Finelli, Antonio
    Lacombe, Louis
    Kawakami, Jun
    Moore, Ronald
    Morash, Christopher
    Black, Peter
    Rendon, Ricardo A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (11) : 486.e1 - 486.e7
  • [35] Epidemiology, diagnosis, and surgical treatment of renal cell carcinoma
    Kurosch, M.
    Reiter, M.
    Haferkamp, A.
    ONKOLOGE, 2014, 20 (09): : 899 - 908
  • [36] Renal cell carcinoma guideline
    Ljungberg, Borje
    Hanbury, Damian C.
    Kuczyk, Marcus A.
    Merseburger, Axel S.
    Mulders, Peter F. A.
    Patard, Jean-Jacques
    Sinescu, Ioanel C.
    ACTAS UROLOGICAS ESPANOLAS, 2009, 33 (03): : 270 - 279
  • [37] Renal cell carcinoma for the nephrologist
    Perazella, Mark A.
    Dreicer, Robert
    Rosner, Mitchell H.
    KIDNEY INTERNATIONAL, 2018, 94 (03) : 471 - 483
  • [38] RFA of renal cell carcinoma in a solitary kidney
    Ralf-Thorsten Hoffmann
    Tobias F. Jakobs
    Christoph Trumm
    Thomas K. Helmberger
    Maximilian F. Reiser
    Abdominal Imaging, 2008, 33 : 230 - 236
  • [39] Radiofrequency ablation of renal cell carcinoma in patients with a solitary kidney: a retrospective analysis of our experience
    Grasso, R. F.
    Luppi, G.
    Faiella, E.
    Giurazza, F.
    Del Vescovo, R.
    Cazzato, R. L.
    Zobel, B. Beomonte
    RADIOLOGIA MEDICA, 2012, 117 (04): : 606 - 615
  • [40] Is technically complicated partial nephrectomy justified in renal cell carcinoma patients with normal contralateral kidney?
    Volkova, M. I.
    Ridin, V. A.
    Cherniayev, V. A.
    Klimov, A. V.
    Figurin, K. M.
    Kirichek, A. A.
    Matveev, V. B.
    ONKOUROLOGIYA, 2019, 15 (04): : 39 - 49